Reliability and Validity of the MINI International Neuropsychiatric Interview for Children and Adolescents (MINI-KID)

Anxiety Disorders Clinical Trial

Official title:

Reliability and Validity of the MINI International Neuropsychiatric Interview for Children and Adolescents (MINI-KID)

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00579267
• Other study ID #: MINI-KID Validation Study
• Status: Completed
• Phase: N/A
• First received: December 18, 2007
• Last updated: February 13, 2009
• Start date: February 2004
• Est. completion date: January 2008

Study information

• Verified date: December 2007
• Source: University of South Florida
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Institutional Review Board
• Study type: Observational

Clinical Trial Summary

The primary aims of this study are to assess:

1. The inter-rater and test-retest reliability of the MINI-KID

2. The validity of the standard MINI-KID interview in relation to the parent rated pencil/paper version (MINI-KID-P) and th longer clinician rated "Schedule for Affective Disorders and Schizophrenia for School Aged Children-Present and Lifetime Version (K-SADS-PL) and "expert opinion" (when available).

Secondary aims will include evaluating the concordance between: The Children's Global Assessment Scale (a required part of the K-SADS) with the clinician-rated Sheehan Disability Scale (to be administered with the MINI-KID) as a measure of illness severity.

Description:

The MINI-KID is a short, structured diagnostic interview used to assess the presence of 24 DSM-IV child and adolescent psychiatric disorders as well as the risk of suicide.

To achieve adequate representation of the major psychiatric disorders and sufficient normal controls, we propose recruiting 230 children and adolescents (ages 6 to 17 years 11 months), comprised of 200 subjects identified as having one or more psychiatric disorders and 30 normal controls in the community. These subjects will be from diverse socioeconomic, racial and ethnic backgrounds. We will assess the inter-rater and test-retest reliability of the MINI-KID and examine its validity with the "gold-standard" diagnostic interview for children and adolescents as well as expert opinion.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 230
• Est. completion date: January 2008
• Est. primary completion date: January 2008
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Both
• Age group: 6 Years to 17 Years

Eligibility

Inclusion Criteria:

• Subjects will be between the ages of 6 years and 17 years, 11 months

• All subjects must meet MINI-KID DSM-IV criteria for a least one of the Axis I child psychiatry disorders covered by the MINI-KID.

• Both sexes are included.

Exclusion Criteria:

• Subjects who suffer from mental retardation, significant developmental disorders, congenital abnormalities, delirium, dementia, a language problem, or brain damage will be excluded.

• Subjects with neurological disorders, chronic or life threatening diseases will be excluded.

Study Design

Observational Model: Case-Only, Time Perspective: Cross-Sectional

Related Conditions & MeSH terms

• ADHD
• Alcohol Dependence
• Alcoholism
• Anxiety Disorders
• Attention Deficit and Disruptive Behavior Disorders
• Autistic Disorder
• Child Development Disorders, Pervasive
• Conduct Disorder
• Depressive Disorder, Major
• Developmental Disabilities
• Disease
• Drug Dependence
• Dysthymia
• Eating Disorders
• Major Depression
• Mania
• Mental Disorders
• Oppositional Defiant Disorder
• Pervasive Developmental Disorder
• Psychotic Disorder
• Psychotic Disorders
• Suicidality
• Tourette Syndrome
• Tourettes Disorder

Intervention

Other:
• MINI-KID
Structured Diagnostic Interview for children and adolescent psychiatric disorders.

Locations

Country	Name	City	State
United States	University of South Florida College of Medicine, Department of Psychiatry	Tampa	Florida

Sponsors (1)

Lead Sponsor	Collaborator
University of South Florida

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Kappa scores between MINI Kid and K-SADS		4 years	No